Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Moneyclipon Oct 27, 2010 12:54pm
305 Views
Post# 17618875

RE: the long haul

RE: the long haulWhen you so far down there is only one way to look, and thats UP! Am I the only one to believe the TBI request from the pentagon may have some influence, direct or indirect on the scheduled FDA meetings regarding stroke? I like the cynergies between the two with regards to breathing life back into SSS. It looks like we have turned the corner and for me  it was time to cautiously re-enter and build a new position after watching on the sidelines for some time

GL
Bullboard Posts